November 23, 2009 (FinancialWire) Novavax, Inc. (NASDAQ: NVAX) has priced an underwritten public offering of 6.8 million shares of its common stock at a price to the public of $3.30 per share. Piper Jaffray & Co. (NYSE: PJC) and Lazard Capital Markets (NYSE: LAZ) are acting as joint book running managers.
The underwriters have been granted an option to purchase up to an additional 1,020,000 shares at any time on or prior to December 8, 2009 to cover over-allotments, if any.
Novavax said it would use the approximately $21 million of net proceeds for preclinical studies and clinical trials of the firms VLP-based vaccines, internal research and development programs, working capital, capital expenditures and other general corporate purposes.
Novavax is a clinical-stage biotechnology company creating novel vaccines to address a range of infectious diseases worldwide, including H1N1, using advanced proprietary virus-like-particle technology.
FinancialWire(tm) is a fully independent, proprietary news wire service. FinancialWire(tm) is not a press release service, and receives no compensation for its news, opinions or distributions. Further disclosure is at the FinancialWire(tm) web site (http://www.financialwire.net/disclosures.php). Contact FinancialWire(tm) directly via inquiries@financialwire.net.
Free annual reports for companies mentioned in the news are available through the Free Annual Reports Service (http://investrend.ar.wilink.com/?level=279).
Novavax Sells 6.8 Million Common Shares December 10, 2009 (FinancialWire) Novavax, Inc. (NASDAQ: NVAX) has closed a public offering of 6.8 million shares of its common stock at $3.30 per share. Piper Jaffray & Co. (NYSE: PJC) and Lazard Capital... |
Biggest Healthcare Stocks Losers were BCRX, NVAX, HLCS : by Penny Stock Pick alert (EMAILWIRE.COM, November 21, 2009 ) Dallas, TX - BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) plunges 8.17% to $9.55 after the company yesterday announced pricing of a public offering of 5,000,000 shares... |
Comverge Prices Common Share Offering November 20, 2009 (FinancialWire) Comverge, Inc. (NASDAQ: COMV) has priced an underwritten offering of 2.4 million shares of common stock at $10.50 per share. RBC Capital Markets (NYSE: RY) and Lazard... |
Microvision Announces Pricing of Public Common Stock Offering November 20, 2009 (FinancialWire) Microvision, Inc. (NASDAQ: MVIS), firm engaged in light scanning technologies, has priced an underwritten public offering of 6.7 million shares of its common stock at... |
Hospitality Properties Trust Prices 8 Million Common Share Offering Hospitality Properties Trust (NYSE: HPT) today announced that it has priced a public offering of 8 million common shares at $17.25 per share.The settlement of this sale is expected to occur on August... |
Novavax, Inc. (NASDAQ:NVAX) Is the Top Active Stock on Nasdaq (EMAILWIRE.COM, August 18, 2009 ) New York, NY - PennyStockPickAlert is pleased to alert investors of stocks on the move. Novavax, Inc. (NASDAQ:NVAX) is currently the top mover in the morning trade... |
